Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan F Leitman

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Blood|February 5, 2009
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramMichael A Pulsipher, Pintip Chitphakdithai, John P Miller, et al.
Journal of the American College of Cardiology|November 1, 2005
Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery diseaseJonathan M Hill, Mushabbar A Syed, Andrew E Arai, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
Blood|June 5, 2008
Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse populationSumithira Vasu, Susan F Leitman, John F Tisdale, et al.
British Journal of Haematology|September 9, 2004
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantationMichael R Bishop, Seth M Steinberg, Ronald E Gress, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSFAndreas Lundqvist, Aleah L Smith, Yoshiyuki Takahashi, et al.
JCI Insight|August 16, 2019
Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controllerStephen A Migueles, Cheryl Chairez, Siying Lin, et al.
Nature Medicine|August 28, 2007
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidinToshihiko Tanno, Natarajan V Bhanu, Patricia A Oneal, et al.
Blood|February 7, 2004
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cellsKouhei Yamashita, Uimook Choi, Patricia C Woltz, et al.
Human Gene Therapy|September 10, 2005
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsRichard A Morgan, Robert Walker, Charles S Carter, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Blood|February 5, 2009
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramMichael A Pulsipher, Pintip Chitphakdithai, John P Miller, et al.
Journal of the American College of Cardiology|November 1, 2005
Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery diseaseJonathan M Hill, Mushabbar A Syed, Andrew E Arai, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
Blood|June 5, 2008
Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse populationSumithira Vasu, Susan F Leitman, John F Tisdale, et al.
British Journal of Haematology|September 9, 2004
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantationMichael R Bishop, Seth M Steinberg, Ronald E Gress, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSFAndreas Lundqvist, Aleah L Smith, Yoshiyuki Takahashi, et al.
JCI Insight|August 16, 2019
Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controllerStephen A Migueles, Cheryl Chairez, Siying Lin, et al.
Nature Medicine|August 28, 2007
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidinToshihiko Tanno, Natarajan V Bhanu, Patricia A Oneal, et al.
Blood|February 7, 2004
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cellsKouhei Yamashita, Uimook Choi, Patricia C Woltz, et al.
Human Gene Therapy|September 10, 2005
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsRichard A Morgan, Robert Walker, Charles S Carter, et al.
Pageof 11